CircuLite
Framingham
About CircuLite
CircuLite is a cardiovascular device company that is transforming heart failure treatment with the development of minimally-invasive micro-pumps for long-term partial circulatory support (PCS). By enabling a proactive and lower-risk treatment approach by supplementing a patient's native pumping capacity, CircuLite has the potential to improve the quality of life for millions of chronic heart failure patients and their families. The company's proprietary micro-pump platform enables its PCS devices to be so small that they can be implanted superficially in a pacemaker-like pocket with endovascular or minimally-invasive surgical techniques.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: Less than $1M
- Total funding: $96.2M
- Funding stage: M&A
- Last round: Series D (Nov 2011)
- Website: circulite.net
- Phone: +1 508-739-0950
Industries & Categories
Health Care, Hospital, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/circulite-2989175 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.